• HOME
  • NEWS
  • EXPLORE
    • CAREER
      • Companies
      • Jobs
    • EVENTS
    • iGEM
      • News
      • Team
    • PHOTOS
    • VIDEO
    • WIKI
  • BLOG
  • COMMUNITY
    • FACEBOOK
    • INSTAGRAM
    • TWITTER
Thursday, November 6, 2025
BIOENGINEER.ORG
No Result
View All Result
  • Login
  • HOME
  • NEWS
  • EXPLORE
    • CAREER
      • Companies
      • Jobs
        • Lecturer
        • PhD Studentship
        • Postdoc
        • Research Assistant
    • EVENTS
    • iGEM
      • News
      • Team
    • PHOTOS
    • VIDEO
    • WIKI
  • BLOG
  • COMMUNITY
    • FACEBOOK
    • INSTAGRAM
    • TWITTER
  • HOME
  • NEWS
  • EXPLORE
    • CAREER
      • Companies
      • Jobs
        • Lecturer
        • PhD Studentship
        • Postdoc
        • Research Assistant
    • EVENTS
    • iGEM
      • News
      • Team
    • PHOTOS
    • VIDEO
    • WIKI
  • BLOG
  • COMMUNITY
    • FACEBOOK
    • INSTAGRAM
    • TWITTER
No Result
View All Result
Bioengineer.org
No Result
View All Result
Home NEWS Science News Biology

Otago scientists investigate monkey malaria threat as potential therapy

Bioengineer by Bioengineer
October 10, 2018
in Biology
Reading Time: 2 mins read
0
Share on FacebookShare on TwitterShare on LinkedinShare on RedditShare on Telegram
IMAGE

Credit: University of Otago

A breakthrough in monkey malaria research by University of Otago scientists encouraged the Bill & Melinda Gates Foundation to fund a special meeting in Dunedin recently.

A rare form of monkey malaria has been recently implicated in a spate of malaria cases in Malaysia. Professor Bruce Russell from the Department of Microbiology and Immunology at the University of Otago says scientists at the University of Otago, the National University of Singapore and University of Georgia (US) have discovered a way to potentially use this monkey malaria known as "Cynomolgi malaria" to help eliminate the relapsing form of human malaria (Vivax malaria), which is a significant burden for tens of millions of people throughout the developing world.

Cynomolgi malaraia parasites are found in the blood of wild populations of monkeys in South-east Asia and Cynomolgi has recently been detected infecting humans living close to forest areas.

"While this new form of malaria outbreak is certainly unwelcome, we are focused on the benefits of studying this zoonotic malaria as a way to help eliminate an important cause of relapsing human malaria, vivax," Professor Russell explains.

"We believe that this monkey malaria parasite will greatly help us in finding therapies to kill the liver stages, which are responsible for the relapsing nature of vivax malaria."

Vivax malaria is the most widely distributed, difficult to diagnose form of human malaria. Current efforts to develop new drugs and vaccines against vivax have been stymied by lack of an in vitro cultured method, he says.

However, fortunately the group of scientists from Otago, Singapore and the US have discovered a way to culture cynomolgi malaria parasites, which are almost identical to vivax malaria.

"The primate malaria we are using can be cultured and studied, whereas the important human malaria parasite vivax cannot be cultured," Professor Russell explains.

"The exciting prospect of developing cynomolgi as a model to study vivax malaria, spurred the Bill & Melinda Gates Foundation to fund a meeting in Dunedin this month, where one of the first successful culture systems were developed."

Professor Russell and Professor Dennis Kyle from the University of Georgia organised a diverse group of internationally-renowned malaria specialists (malariologists) from industry, government and academia to participate in the eight-day workshop and conference in Dunedin. The conference was completely funded by the Gates Foundation.

"This type of intenseive hands-on workshop encouraged a high-level of interaction, where a new international consortium of scientists emerged with a new tool to overcome current bottlenecks in vivax malaria research," Professor Russell says.

Aside from providing an exciting new way to understand vivax malaria, the new in vitro method significantly replaces preclinical testing of new drugs in animals, he says.

###

For more information, please contact:

Professor Bruce Russell
Department of Microbiology and Immunology
Tel 03 479 7082
Mob 027 434 5387
Email [email protected]

Liane Topham-Kindley
Senior Communications Adviser
Tel 03 479 9065
Mob 021 279 9065
Email [email protected]

Media Contact

Liane Topham-Kindley
[email protected]
64-212-799-065
@otago

http://www.otago.ac.nz

Original Source

https://www.otago.ac.nz/news/news/otago697529.html

Share12Tweet8Share2ShareShareShare2

Related Posts

blank

Island reptiles risk extinction before scientific study, warns global review

November 6, 2025
Revamping Genome-Wide Metabolic Model for Streptococcus suis

Revamping Genome-Wide Metabolic Model for Streptococcus suis

November 6, 2025

Commonly Used Pesticides Linked to Reduced Sperm Count

November 5, 2025

Gender, Surgery Side Influence Epilepsy Surgery Outcomes

November 5, 2025
Please login to join discussion

POPULAR NEWS

  • Sperm MicroRNAs: Crucial Mediators of Paternal Exercise Capacity Transmission

    1299 shares
    Share 519 Tweet 324
  • Stinkbug Leg Organ Hosts Symbiotic Fungi That Protect Eggs from Parasitic Wasps

    313 shares
    Share 125 Tweet 78
  • ESMO 2025: mRNA COVID Vaccines Enhance Efficacy of Cancer Immunotherapy

    205 shares
    Share 82 Tweet 51
  • New Study Suggests ALS and MS May Stem from Common Environmental Factor

    138 shares
    Share 55 Tweet 35

About

We bring you the latest biotechnology news from best research centers and universities around the world. Check our website.

Follow us

Recent News

Atomically Precise Antibody Design via RFdiffusion

Breakthrough Hyperspectral Camera Captures First Precise Altitude Map of Blue Aurora

Evaluating Phylogenetic Confidence During Pandemics

Subscribe to Blog via Email

Enter your email address to subscribe to this blog and receive notifications of new posts by email.

Join 68 other subscribers
  • Contact Us

Bioengineer.org © Copyright 2023 All Rights Reserved.

Welcome Back!

Login to your account below

Forgotten Password?

Retrieve your password

Please enter your username or email address to reset your password.

Log In
No Result
View All Result
  • Homepages
    • Home Page 1
    • Home Page 2
  • News
  • National
  • Business
  • Health
  • Lifestyle
  • Science

Bioengineer.org © Copyright 2023 All Rights Reserved.